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Separation of isomeric glycans by ion mobility
spectrometry – the impact of ﬂuorescent
labelling†
Christian Manz, a,b Márkó Grabarics,a,b Friederike Hoberg,b Michele Pugini,a,b
Alexandra Stuckmann,a Weston B. Struwe *c and Kevin Pagel *a,b
The analysis of complex oligosaccharides is traditionally based on multidimensional workﬂows where
liquid chromatography is coupled to tandem mass spectrometry (LC-MS/MS). Due to the presence of
multiple isomers, which cannot be distinguished easily using tandem MS, a detailed structural elucidation
is still challenging in many cases. Recently, ion mobility spectrometry (IMS) showed great potential as an
additional structural parameter in glycan analysis. While the time-scale of the IMS separation is fully com-
patible to that of LC-MS-based workﬂows, there are very few reports in which both techniques have been
directly coupled for glycan analysis. As a result, there is little knowledge on how the derivatization with
ﬂuorescent labels as common in glycan LC-MS aﬀects the mobility and, as a result, the selectivity of IMS
separations. Here, we address this problem by systematically analyzing six isomeric glycans derivatized
with the most common ﬂuorescent tags using ion mobility spectrometry. We report >150 collision cross-
sections (CCS) acquired in positive and negative ion mode and compare the quality of the separation for
each derivatization strategy. Our results show that isomer separation strongly depends on the chosen
label, as well as on the type of adduct ion. In some cases, ﬂuorescent labels signiﬁcantly enhance peak-
to-peak resolution which can help to distinguish isomeric species.
Introduction
Carbohydrates are the most abundant biopolymers on Earth.1
The majority are large and regular polysaccharides, which
often serve as structural scaﬀolds such as in cellulose, or
energy sources in nutrition such as in starch. However, many
biological functions are performed by smaller, more complex
oligosaccharides, often referred to as glycans. They for
example play a role in the prebiotic nutrition of infants2 and
regulate immune responses.3,4 In contrast to oligonucleotides
and peptides, the biosynthesis of oligosaccharides is not tem-
plate-driven, leading to structures that are highly diverse with
a complex branching pattern, regio- and stereochemistry. Mass
spectrometry (MS) analysis is in most cases not suﬃcient to
unambiguously identify the structure of glycans, since mul-
tiple isomers often coexist. As a result of this complexity, an
in-depth glycan analysis still presents a major analytical
challenge.5
A common way to resolve and separate glycan isomers is
liquid chromatography (LC). Reversed phase (RP) chromato-
graphy, which is commonly used for protein analysis, often
struggles with glycans due to their inherently high polarity.
Instead, other stationary phases such as hydrophilic inter-
action chromatography (HILIC) and porous graphitic carbon
(PGC) are often applied as an alternative, powerful way to sep-
arate glycan isomers.6 However, as glycans naturally do not
contain chromophores or fluorophores, it is often necessary to
derivatize them with fluorescent labels to facilitate a suﬃcient
detection and enable quantification.7
Another emerging and promising technique capable of sep-
arating glycan isomers is ion mobility spectrometry (IMS).5,8,9
Here, ions travel through a drift cell filled with an inert buﬀer
gas under the influence of a weak electric field and undergo
low-energy collisions with the buﬀer gas. Compact ions collide
less frequently with the buﬀer gas than more extended ions,
which leads to a separation based on size, shape and charge.
This enables the separation of isomeric species as shown for
small molecules,10 oligosaccharides as well as for
glycoconjugates.11,12 In addition, the resulting drift times can
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be converted into the rotationally averaged collision cross-
section (CCS). When measured under controlled conditions,
CCSs can be universally compared, which enables an eﬃcient
incorporation into databases to allow for structural
elucidation.13–17 While over the last several years both LC and
IMS, showed their individual capabilities to resolve glycan
isomers, very few attempts have been made to combine both
methods into a consistent LC-IM-MS workflow for glycan ana-
lysis.18 Importantly, the impact of derivatization, in particular
with fluorescence labels, on the mobility separation of iso-
meric glycans is poorly understood. To close this gap, we
present a systematical analysis using a set of isomeric glycans
derivatized with diﬀerent common glycan fluorophores as well
as native and reduced species. Our data indicate that labelling
can significantly aﬀect the ability to separate individual glycan
isomers via IM-MS. Depending on the label, this can diminish
or improve selectivity, and therefore, labels should be specifi-
cally selected for a given glycan analysis.
Experimental
Sample preparation
All labelling reagents and solvents were purchased from Sigma
Aldrich (St Louis, USA) and used without further purification.
Synthetically derived Lewis oligosaccharides were purchased
from Dextra Laboratories Ltd (Reading, UK). Prior to analysis,
the Lewis antigens were diluted to 1 mM stock solution in
HPLC grade water. The stock solution was divided into 10 µL
(10 nmol) aliquots and freeze dried. Dried Lewis antigens were
labelled with 2-aminobenzoic acid (2-AA), 2-aminobenzamide
(2-AB), 4-amino-N-[2-(diethylamino)ethyl]benzamide (procain-
amide, ProA) via reductive amination.19 Removal of excess
label was performed using paper chromatography.20 Alditols
were synthezised via reduction with sodium borohydride.21
The reduced, as well as 2-AB, 2-AA and ProA labelled glycans
were further purified using HyperSep Hypercarb SPE cartridges
(ThermoFisher Scientific, Waltham, Massachusetts, US)
according to manufacturer’s instructions. Afterwards, the puri-
fied glycans were freeze dried and redissolved in HPLC grade
water to yield a ∼100 µM stock solution.
Ion mobility-mass spectrometry
Linear drift tube (DT) IM-MS measurements were performed
on a modified Synapt G2-S HDMS instrument (Waters
Corporation, Manchester, UK), described in detail elsewhere.22
Measurements were performed in positive and negative ion
mode with platinum/palladium (Pt/Pd, 80/20) coated boro-
silicate capillaries prepared in-house. Prior to measurements,
each sample was diluted from stock solution with methanol :
water (1 : 1) to result in a final concentration of 10 µM. Salt
solutions were generated by adding a 10 mg mL−1 aqueous
stock solution of KCl/LiCl/NaCl to the labelled glycan solution
to result in a 1 : 5 ratio (salt : glycan).
For nano-electrospray ionization (nano-ESI) typically 5 µL of
sample was loaded to a capillary and electrosprayed by apply-
ing a capillary voltage of 0.6–1.1 kV. Typical parameters in
positive ion mode were: 60 V sampling cone voltage, 1 V
source oﬀset voltage, 30 °C source temperature, 0 V trap CE
(MS) up to 30 V trap CE (MSMS), 2 V transfer CE, 3 mL min−1
trap gas flow. Ion mobility parameters were: 2.2 Torr helium
IMS gas, 27–30 °C IMS temperature, 5.0 V trap DC entrance
voltage, 5.0 V trap DC bias voltage, −10.0 V trap DC voltage,
2.0 V trap DC exit voltage, −25.0 V IMS DC entrance voltage,
50–180 V helium cell DC voltage, −40.0 V helium exit voltage,
50–150 V IMS bias voltage, 0 V IMS DC exit voltage, 5.0 V trans-
fer DC entrance voltage, 15.0 V transfer DC exit voltage, 150 m
s−1 trap wave velocity, 1.0 V trap wave height voltage, 200 m s−1
transfer wave velocity, 5.0 V transfer wave height voltage.
In negative ion mode typical parameters were: 90 V
sampling cone voltage, 10 V source oﬀset voltage, 30 °C source
temperature, 0 V trap CE (MS) up to 30 V trap CE (MSMS), 2 V
transfer CE, 3 mL min−1 trap gas flow. Ion mobility parameters
were: 2.2 Torr helium IMS gas, 27–30 °C IMS temperature, 1.0
V trap DC entrance voltage, 2.0 V trap DC bias voltage, −1.0 V
trap DC voltage, 1.5 V trap DC exit voltage, −25.0 V IMS DC
entrance voltage, 50–150 V helium cell DC voltage, −40.0 V
helium exit voltage, 50–150 V IMS bias voltage, 0 V IMS DC exit
voltage, 5.0 V transfer DC entrance voltage, 15.0 V transfer DC
exit voltage, 200 m s−1 trap wave velocity, 10.0 V trap wave
height voltage, 250 m s−1 transfer wave velocity, 3.0 V transfer
wave height voltage. The resulting drift times were converted
to rotationally-averaged collision cross-sections (CCS) using
the Mason–Schamp equation.23
Results and discussion
ABO and Lewis blood group system
A common and widely studied set of isomeric glycans are the
epitopes of two diﬀerent blood group systems: the Lewis anti-
gens (Le) and the ABO blood group system (H antigen, com-
monly referred to as BG H). These structures are typically found
as features on larger glycoconjugates such a N- and O-linked
glycans or on human milk oligosaccharides (HMO).24 The two
main types of Lewis antigens are the tetrasaccharide motifs LeY
and LeB, which feature a common monosaccharide compo-
sition and are displayed in Fig. 1. Type 1 antigens (LeB series)
consist of galactose (Gal) β-(1→3) linked to N-acetylglucosamine
(GlcNAc) core, whereas type 2 antigens (LeY-series) contain a
β-(1→4) linked core. Both antigens are functionalized by two
diﬀerently attached fucose (Fuc) units. The loss of one fucose
unit leads to the regioisomeric trisaccharides LeX and BG H2
(LeY-series) or LeA and BG H1 (LeB-series). In larger glycan
structures, epitopes are formed by terminal fucosylation. Each
of the resulting epitopes has specific functional properties and
alteration is often associated with pathological processes,
including cancer progression and atherosclerosis.26,27
Recently, we investigated these isomeric tri- and tetrasacchar-
ides in an underivatized form using IM-MS and showed that
fragment CCS can be used as fingerprints to systematically
diﬀerentiate between the epitopes.28 The intact tetrasaccharide
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precursors exhibit very similar drift times and CCS, which
makes it diﬃcult to distinguish them using IMS. However,
fragmentation of the tetrasaccharide precursors with collision
induced dissociation (CID) yields trisaccharide fragments that
can be used to identify specific terminal fucose motifs. Some of
those isomeric fragments such as LeX and BG H2 can be readily
distinguished by IMS, while LeA and BG H1 are diﬃcult to diﬀer-
entiate in underivatized form. In the present study, we focus on
the IMS separation of derivatized forms of these epitopes.
Labelling of glycans
Common glycan derivatization strategies, not only for the ABO
and Lewis system, include permethylation, reduction, and
various reducing end modifications via reductive amination.19
Reducing end modifications have been studied extensively,
namely the influence of fluorescent labels on retention in
various chromatographic modes,29–31 ionization eﬃciency in
electrospray ionization (ESI),32 fragmentation patterns in
MS33,34 and on rearrangement reactions of glycan ions.35,36 On
the other hand, very little is known about their influence on
ion mobility separations. In the present study, we focus on the
four most common reducing end modifications to study their
influence on IMS separation (Fig. 2). Due to the high labelling
eﬃciency of reductive amination and the stability of the result-
ing labelled glycans, the fluorophores 2-aminobenzoic acid
(2-AA) and 2-aminobenzamide (2-AB) are currently the most
commonly used labels. They are readily available and known
for their sensitivity in fluorescence detection. Procainamide
(ProA) is a beneficial fluorophore used for coupling LC with
MS because its tertiary amine moiety significantly enhances
ionization eﬃciency in matrix-assisted laser desorption/ioniza-
tion (MALDI) and ESI.37,38 Since all three labels have a hydro-
phobic character, they increase retention of the inherently
polar glycans in reversed-phase separations. As only one label
is incorporated per individual glycan, derivatization with 2-AA,
2-AB or ProA furthermore enables a simple quantification.39
After reductive amination with fluorescent labels such as
2-AB, 2-AA or ProA, the reducing end monosaccharide will
exhibit an open ring structure. To study the influence of this
ring opening, we reduced glycans to open-ring alditols (Red) to
compare them with the predominantly closed-ring native
structures. The reduction of glycans often precedes permethyl-
ation, but alditols themselves are also often used as standa-
lone modification for various stationary phases.39
Ion mobility separation of labelled glycans
In order to address the impact of labelling on the CCS of
glycans, the set of blood group antigens shown in Fig. 1 was
subjected to reducing end modifications displayed in Fig. 2. For
all modified species the drift times in helium drift gas were
measured and CCSs calculated (DTCCSHe). Measured arrival
time distributions (ATDs) of the two fucosylated trisaccharide
isomer pairs LeX/BG H2 and LeA/BG H1 as sodiated species
with diﬀerent reducing end modifications are shown in Fig. 3.
All ATDs were measured under the very same instrumental con-
ditions (such as pressure, drift voltages and drift gas).
As native glycans, LeA and BG H1 show minor isomer separ-
ation compared to LeX and BG H2, which are almost baseline
separated. Compared to the native closed-ring structure, the
ring opening during reduction to alditols does not seem to
have a significant impact on the separation of LeA and BG H1.
In contrast, the drift-time diﬀerence of LeX and BG H2
decreases significantly after reduction. This eﬀect is further
amplified after introduction of the chromophore labels ProA,
2-AA and 2-AB. 2-AA and 2-AB labelled glycans show the largest
isomer separation for the LeA and BG H1 isomers, while LeX
and BG H2 are basically indistinguishable.
Similarly, all native and derivatized isomers were measured
as alkali metal adducts, which are known to significantly alter
isomer separation in IMS.40 Negatively charged adducts such
as chloride and nitrate complexes predominantly lead to the
formation of deprotonated ions, which are therefore the only
ions with negative polarity studied here.41,42 In Table 1, the
Fig. 1 The investigated set of isomeric blood group epitopes. (a)
Tetrasaccharide Lewis B (LeB) and the corresponding trisaccharide frag-
ments/motifs Lewis A (LeA) and blood group H1 (BG H1). (b)
Tetrasaccharide Lewis Y (LeY) and the corresponding trisaccharide frag-
ments/motifs Lewis X (LeX) and blood group H2 (BG H2). (c) Glycan
structures are depicted using the SNFG nomenclature.25
Fig. 2 Reducing end modiﬁcations investigated in this study. (a) Native
glycan and the reduced alditol structure without chromophore at redu-
cing end. (b) Glycan derivatization with chromophore such as procaina-
mide (ProA), 2-aminobenzoic acid (2-AA) and 2-aminobenzamide (2-AB)
is a common strategy to increase sensitivity and enable quantiﬁcation.
For some labels there are additional beneﬁts such as an improved
ionization eﬃciency in ESI or an improved selectivity in HPLC.
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CCSs of protonated and deprotonated glycans, as well as for
three commonly observed typical alkali adducts (Li+, Na+, K+)
measured in helium (DTCCSHe) are shown. The upper part of
Table 1 shows the CCSs of all derivatives and metal adducts of
the LeB series, while the lower part shows the CCSs of all
modifications of the LeY series. The exact masses of all
labelled glycans are shown in Table S1.†
Generally, there is a clear trend of increasing CCS from the
native glycans up to the ProA-labelled glycans. The CCSs for all
species is growing proportionally to the size of the added fluo-
rescent label, and is therefore correlated to the increase in
molecular mass.40 A similar trend is observed with the
addition of alkali metals, which generally lead to larger CCSs
in the order of H+ < Li+ < Na+ < K+. Deprotonated species on
the other hand behave similarly counterparts. However, there
are some exceptions to this behaviour. Especially alditols (Red)
seem to have their largest CCS when protonated or adducted
with potassium, while sodiated and lithiated species show sig-
nificantly smaller CCSs. Another example are glycans labelled
with 2-AA, whose protonated species show larger CCSs than
metal adducted species, which indicates a compaction of the
gas-phase structure with the addition of small alkali metal
ions. This behaviour is a result of the structure of the oligosac-
charide-metal complex, which is dictated by the solvation of
the metal cation.
Comparison of isomeric labelled glycan isomers
As shown above, the CCS of each species strongly depends on
the modification of the reducing end and the type of adduct.
The type of label will therefore also aﬀect the ability to separate
isomers. Based on the CCS for each individual species it is
diﬃcult to rank the quality of each individual separation. A
highly useful index for evaluating this performance is the peak-
to-peak resolution (Rs). It serves as a quantitative measure of the
extent to which a pair of peaks is separated. The definition of
Rs – universally accepted in column chromatography, ion mobi-
lity spectrometry, etc. – is given by the following equation:
Rs ¼ t2  t12σ2 þ 2σ1 ð1Þ
Here, 2σ is the temporal peak width measured between the
two inflection points of a peak of Gaussian profile and t the
drift time. In case of separating isomers of the same charge
state by linear drift tube ion mobility spectrometry (DTIMS),














In eqn (2) N and Rˉp are the average plate number and
average resolving power, respectively (the latter one should not
be confused with peak-to-peak resolution). The relation





, the origin of the constant in the formula
being the diﬀerence between the standard deviation and the
full-width-at-half-maximum (FWHM) of Gaussian distri-
butions. The fraction ΔCCSj j=CCS is the relative diﬀerence
between the collision cross sections of the ions that are to be
separated, i.e. it is a measure of selectivity. In following, we
Fig. 3 ATDs and DTCCSHe of the isomeric blood group epitopes LeA vs.
BG H1 (left panel) and LeX vs. BG H2 (right panel) as sodium adducts in
He drift gas.
Table 1 Comprehensive overview over all CCSs measured in helium for
native and derivatized glycans
DTCCSHe (Å
2) Type Native Red 2-AB 2-AA ProA
LeB [M + H]+ 167 167 189 189 209
[M + Li]+ 165 159 179 178 209
[M + Na]+ 166 160 180 178 210
[M + K]+ 166 164 182 180 214
[M − H]− 165 161 184 179 218
LeA [M + H]+ 144 144 168 167 183
[M + Li]+ 143 138 159 158 188
[M + Na]+ 145 141 161 159 190
[M + K]+ 145 146 163 163 194
[M − H]− 143 141 162 160 190
BG H1 [M + H]+ 144 144 170 168 188
[M + Li]+ 146 142 167 167 195
[M + Na]+ 147 143 169 168 195
[M + K]+ 145 146 169 170 193
[M − H]− 143 143 163 157 192
LeY [M + H]+ 171 169 190 191 209
[M + Li]+ 163 163 190 190 219
[M + Na]+ 164 164 192 191 218
[M + K]+ 165 166 192 191 217
[M − H]− 167 164 185 183 213
LeX [M + H]+ 144 145 169 170 188
[M + Li]+ 138 141 169 165 202
[M + Na]+ 140 142 171 168 202
[M + K]+ 141 144 171 169 198
[M − H]− 146 141 161 159 189
BG H2 [M + H]+ 144 145 172 166 185
[M + Li]+ 148 145 170 169 201
[M + Na]+ 148 146 171 170 201
[M + K]+ 149 148 172 172 197
[M − H]− 144 139 163 155 190
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used this term to describe the diﬀerence in CCS between the
tetrasaccharide isomer pair LeY/LeB as well as the tri-
saccharide isomer pairs LeX/BG H2 and LeA/BG H1 and visual-
ize this diﬀerence as heat map in Table 2.
The upper part of Table 2 shows the isomer separation for
the tetrasaccharides LeY/LeB. Here two general trends are
observed: (1) isomer separation is increased when a fluo-
rescent label is introduced and (2) isomer separation is
improved upon adduct formation with alkali metal adducts.
There are, however, significant diﬀerences between each
individual modification. While native tetrasaccharides only
show up to 2.4% CCS diﬀerence, 2-AA and 2-AB labelled
species separate much better with a diﬀerence of up to 6.9%
for sodium adducts. ProA-labelled isomers, on the other
hand, are separated as lithiated species with a diﬀerence of
4.9%. Thus, specific labels can increase isomer separation,
which in some cases makes them beneficial for IMS
separation.
A very similar behaviour of improved separation is observed
for the LeB submotifs LeA vs. BG H1. Native structures of these
isomers do practically not separate in IMS independent of the
charge carrier; only lithiated and sodiated species do show
minor diﬀerences up to 2.1%. In contrast, a functionalization
with fluorescent labels yields considerably diﬀerent CCSs,
which diﬀer up to 5.5%.
However, as shown for the LeY submotifs LeX vs. BG H2,
the above-mentioned trends cannot be generalized and may in
some cases even be reversed. Here, the native, underivatized
form of the glycan show a diﬀerence of 7% in CCS for lithium
adducts. Upon modification of the reducing end, the quality of
the separation suﬀers drastically. With up to 3% diﬀerence
alditol structures may be resolvable on some instruments, while
2-AA, 2-AB and ProA labelled ions cannot be distinguished
(<2%). Remarkably, although the trend is reversed for the tri-
saccharide isomer pairs LeA/BG H1 and LeX vs. BG H2, the
average CCS diﬀerence is similar at ∼2%. For the tetrasacchar-
ides, the CCS diﬀerence is even larger with almost 3%.
To evaluate which CCS diﬀerence is suﬃcient to identify
two isomeric species in a mixture, the resolving power from
eqn (2) has to be considered. Besides showing the most impor-
tant factors that influence and, ultimately, determine Rs in
DTIMS, eqn (2) also provides a means to calculate the required
resolving power (Rp) to achieve a specified peak-to-peak resolu-
tion for a given pair of ions. If the relative CCS diﬀerence of
two ions is 2%, a resolving power of 64 (corresponding to a
plate number of 22 500) is required to distinguish them (i.e.
separation with a peak-to-peak resolution of Rs = 0.75). To
achieve baseline resolution for the same two peaks (Rs = 1.5),
the resolving power has to be substantially higher, approxi-
mately 127 (corresponding to a plate number of 90 000). This
is already achievable with state-of-the-art custom-built and
commercial instruments and shows that IMS can be readily
applied for isomer separations, as shown in this study for
fucose-containing isomers.
The impact of labelling on fucose migration
The isomer pairs LeA/BG H1 and LeX/BG H2 are known to
undergo fucose migration as protonated ions. Fucose
migration is a gas-phase rearrangement reaction during which
fucose residues relocate within a glycan during a MS experi-
ment. As a result, sequence information can get lost in
tandem MS experiments, which can lead to erroneous struc-
tural assignments.43 Traditionally, fucose migration was
always closely related to a fragmentation via CID.36 However,
more recent studies using cold-ion IR spectroscopy showed
that fucose migration reactions have a rather low activation
barrier and can therefore also occur without dissociation.35,44
In this context, the type of adduct as well as the position of the
charge was shown to be crucial.41 Metal adducts generally do
not show fucose migration; protonated species on the other
hand can rearrange when the proton is mobile and located at
a certain position within the glycan.35
The results of the isomer pairs LeA/BG H1 and LeX/BG H2
obtained here fully agree with those of previous reports. LeA/
BG H1 as well as LeX/BG H2 yield very similar CCSs as proto-
nated ions and the ATDs overlap perfectly, which indicates
migration into a similar structure. A similar behaviour can by
hypothesized for protonated reduced glycans, which show very
similar CCSs that are well within the error of the measurement
(relative standard deviation (RSD) of 0.5%).45 However, based
on the present data a clear conclusion cannot be drawn. In
strong contrast, most of the metal adducts diﬀer substantially
in CCS, which clearly contradicts a rearrangement reaction.
Labelling with 2-AA, 2-AB and ProA not only changes the UV
and fluorescence activity of the glycan, but also introduces
apparent basic sites, which reduces or inhibits proton mobility.
As a result, diﬀerent structures leading to distinct CCSs are
retained. Fluorescence labelling can therefore not only help to
Table 2 CCS diﬀerences of the three derivatized fucose-containing
isomer pairs LeY/LeB, LeX/BG H2 and LeA/BG H1 displayed as heat map
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increase isomer separation in IMS as shown above, but can also
inhibit fucose migration in protonated glycan ions.
Conclusions
Here we systematically evaluate the impact of reducing end
modifications on the CCS and isomer separation of glycans. A
set of Lewis and ABO blood group isomers was derivatized
using labels established in LC. Their DTCCSsHe were measured
in positive and negative ion polarity. Furthermore, the influence
of alkali metal salt adduction was evaluated. Our results show
that fluorescent labels can significantly influence the gas-phase
structure of glycans. As a result, reducing end modifications can
considerably improve, but in some cases also diminish the
quality of a given isomer separation. Based on the limited set of
investigated glycans, no general trends to increase selectivity
was observable. Therefore, more glycans have to be analysed in
order to predict, which reducing-end modification is required
to optimize a particular isomer separation.
Seen from a broader perspective, the presented data show the
great potential of an LC-IM-MS coupling for glycomics. Both
methods have previously shown their individual strengths and
weaknesses in glycan analysis. LC can resolve and quantify certain
isomers and retention indices (i.e. glucose units46) can be used
for the structural identification of known components. IM-MS on
the other hand is more sensitive and can also resolve isomers
with an amphiphilic character such as synthetic glycans or glyco-
lipids, which due to their mixed polarity can often not be separ-
ated by LC.11 In addition, fragmentation and subsequent IMS ana-
lysis enables the rapid identification of unknown components
based on database CCSs of small fragments.12,13,28 Regarding
time scale, LC and IM-MS are furthermore highly complementary
and data can be obtained simultaneously on a high-throughput
scale.47,48 A combination of LC and IM-MS is therefore highly
synergistic and more than the sum of its parts. When combined
with suitable software tools to annotate tandem MS spectra and
calculate glucose units49 and CCSs,50 LC-IM-MS has the potential
to serve as the future core technology in glycomics.
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